Science

Event Profile: Naidex is the UK's largest homecare, disability and rehabilitation event, and this year's show was the biggest ever, an opportunity for users, carers and healthcare professionals to view a wide range of products and services. Highlights: Using Web-Based Resources to Support CPD for Health Professionals, A National Framework for Support Worker Education and Development (Jointly developed by the COT and the CSP), The Implications of the Green Paper on Adult Social Care. Visitor's Profile: Physios, OT's, speech and language therapists, community loan store managers, specifiers, dealers, people with varying disabilities, their carers, families and friends are the target audience. Exhibitor's Profile: Profile for exhibit include bathing and showers, moving & handling, lifts and hoists, seating & stairlifts to pressure relief, paediatric equipment, communication products and services. Organizer: Emap Business Europe Wentworth House, Wentworth Street, Peterborough, PE1 1DS, Emap plc, 40 Bernard Street, London, United Kingdom. Tel: +(44)-(208)-2775844 Fax: +(44)-(208)-2775887

Event Profile: There is no better way for UK medical device manufacturers to effectively and efficiently see, compare, and evaluate the complete range of product and service resources for designing and manufacturing current and next-generation medical devices and equipment (Medtec UK) Highlights: Content for the technical conference changes year-on-year and topics are generated through delegate and industry feedback. Visitor's Profile: Pharma Formulators, API, Drug Intermediates, Excipients, Natural Extracts, Contract Researchers, Custom Manufacturers, Packaging Equipment / Materials, Quality Assurance & Control, Product Development Services, Laboratory & Processing Equipment Manufacturers, Trade Publications, Contract Research, Contract Processing are the target audience. Exhibitor's Profile: Contract Manufacturing & Subcontracting, Component Fabrication, Tubing Adhesives & Adhesive Products, Electronic Components, Production/Assembly, Packaging Equipment & Materials, Motors & Motion Control, Plastics Testing Equipment & Services Hardware & IV Components Precision Metalworking, Tooling, and Machining Organizer: Canon Communications 11444 W. Olympic Blvd., Ste. 900, Los Angeles, United States of America. Tel: +(310)-(4)-454200 Fax: +(310)-(4)-454299

Controversies and Cases in Obstetric Anaesthesia 27 February 2008 London, United Kingdom Website: http://www.oaameetings.info Contact name: OAA Secretariat Organized by: Obstetric Anaesthetists’ Association

Achieving NHS Productivity 27 to 28 February 2008 Manchester, United Kingdom Website: http://www.hsj-productivity.co.uk Contact name: Customer Service Health Service Journal brings you two one-day conferences that focus on achieving productivity in the NHS. Tackling two key service areas - theatres and wards. Organized by: HSJ Conferences

Environmental Monitoring & OSPAR Compliance 2008 26 to 28 February 2008 Aberdeen, United Kingdom Website: http://www.iqpc.com/uk/ospar Contact name: Swaantje Buss Attending Energy IQ’s Environmental Monitoring & OSPAR Compliance 2008 will enable you to enhance your oil-in-water monitoring processes and ensure you are complying fully with the latest OSPAR regulations. Organized by: IQPC

Since 1984 when the world was informed of the menace of HIV/AIDS and our subsequent waking up from lack of action, the world has being mobilizing itself to fight this deadly menace. Each day, each minute and each second brings new challenges to all of us; from the danger of stigma to the what seems like an unwinnable war of ARV drug resistance. As the world keeps wondering what next, this conference will bring together all stakeholders in HIV/AIDS and for this year, we want to look at those challenges and how we can hypothetically address them. Attending this conference will not be only academically viable but also attendees will have the opportunities of meeting some commercial and non-commercial bodies whose efforts in HIV/AIDS are quite phenomenon and secondly it will give the avenue to network especially with the Africa Health Research Organization's highly innovative HIV/AIDS Working Group. The event from this year will be held annually. See you at London 2007

What is the Training Institute on Behavioral Health and Addictive Disorders? A premier training event, specializing in mental health and the addictions field. The Institute for Integral Development and US Journal Training, Inc. offer a unique combination of nationally recognized faculty who can address a wide variety of today's most relevant topics. The results are highly acclaimed national training events featuring customized training opportunities for developing new treatment strategies and research advances for clinicians and counselors. A maximum of 27 Contact Hours are available for this Conference. 23 core credit hours (6 hours for M, T, W, 5 hours for Th) and 4 evening hours (2 per evening). This conference includes 3 Hours Ethics and Boundaries, 2 Hours Medical Errors and 1 Hour HIV/Aids Update. Full-Time conference attendees who complete all required evaluation and attendance documentation are eligible to receive the maximum number of contact hours. Daily registrants can receive credit for each day in attendance. What is the Training Institute on Behavioral Health and Addictive Disorders? A premier training event, specializing in mental health and the addictions field. The Institute for Integral Development and US Journal Training, Inc. offer a unique combination of nationally recognized faculty who can address a wide variety of today's most relevant topics. The results are highly acclaimed national training events featuring customized training opportunities for developing new treatment strategies and research advances for clinicians and counselors. A maximum of 27 Contact Hours are available for this Conference. 23 core credit hours (6 hours for M, T, W, 5 hours for Th) and 4 evening hours (2 per evening). This conference includes 3 Hours Ethics and Boundaries, 2 Hours Medical Errors and 1 Hour HIV/Aids Update. Full-Time conference attendees who complete all required evaluation and attendance documentation are eligible to receive the maximum number of contact hours. Daily registrants can receive credit for each day in attendance.

The Aspergillus field is in a state of rapid advancement, including the publications of the genomes of Aspergillus fumigatus, Aspergillus nidulans and Aspergillus oryzae providing a huge impetus for basic research. Additionally, the launch of several newer antifungals in the last few years and anticipated clinical trials of several more is an important therapeutic step forward, without precedent in mycology. Despite the incidence of invasive aspergillosis increasing and the disease being the leading fungal cause of patient mortality, prior to the 2004 AdvancesAgainst Aspergillosis meeting there had been little communication among experts in the area. This is another chance to gather the world's aspergillosis experts in one venue. A fundamental tenet of this research colloquium continues to be to engender collaborative relationships amongst clinicians, scientists, and industry to further advance the field.

SPECIFIC OBJECTIVES – DAY 1 - CLINICAL AND LABORATORY APPROACH TO RHEUMATIC DISEASES – Approach to the evaluation of the patient with rheumatic disease including: Relate the central role of the history and physical examination. Key x-ray findings in patients with rheumatic diseases. Importance of synovial fluid analysis. Use and limitations of laboratory testing. OSTEOARTHRITIS: DIAGNOSIS AND TREATMENT – Distinguish osteoarthritis from other forms of arthritis. Appropriate use of medical, physical and surgical treatments. MANAGEMENT OF TYPE 1 DIABETES – Diagnostic criteria for the diagnosis of diabetes. New insulin regimens for intensive glucose control. Screen for and manage cardiovascular complications of diabetes based on evidence-based studies. TREATMENT STRATEGIES IN TYPE 2 DIABETES – New pharmacologic agents available for glucose control. Apply concepts of pathophysiology to the selection of pharmacotherapy for Type 2 diabetes. Cost-effective approach to the management of diabetic complications. DAY 2 - POLYCYSTIC OVARY SYNDROME – Concepts in risk factors and pathophysiology. Simple laboratory screening process for diagnosis. Apply pathophysiology to design a treatment strategy. ADRENAL CASE STUDIES – Evaluation of the incidental adrenal mass. Diagnose and treat adrenal insufficiency. Manage patients with excessive adrenal steroid levels. CLINICAL ASPECTS OF RHEUMATOID ARTHRITIS – Clinical features of rheumatoid arthritis. The systemic nature of the disease. TREATMENT OF RHEUMATOID ARTHRITIS – Approach to the treatment of rheumatoid arthritis. Use and toxicity of disease modifying agents. DAY 3 - CRYSTAL ARTHROPATHIES – Describe the diagnosis and treatment of crystal arthropathies including gout and pseudogout. OSTEOPOROSIS: EVALUATION AND TREATMENT – Pathophysiology and epidemiology of osteoporosis. Role of bone mineral density measurement in the diagnosis of osteoporosis. Nonpharmacologic and pharmacologic treatments for osteoporosis. THE DYSLIPIDEMIAS: EVIDENCE-BASED DECISION MAKING – Landmark outcomes studies in reducing cardiovascular risk. Lipid lowering therapies. Apply evidence based protocols to at-risk patients. DISORDERS OF CALCIUM METABOLISM – Differential diagnosis of hypercalcemia. Cost effective workup to elevated calcium states. Evaluate hypocalcemic disorders using common laboratory studies. DAY 4 - THYROID CASE STUDIES, PARTS 1 & 2 – Etiologies and pathogenesis of hyper and hypothyroidism. Cost effective principles in the laboratory evaluation of thyroid conditions. Treatment protocols for various thyroid conditions. PSORIATIC ARTHRITIS AND THE SPONDYLOARTHROPATHIES – Clinical features of psoriatic arthritis and the spondyloarthropathies. Treatment modalities. SYSTEMIC LUPUS AND CONNECTIVE TISSUE DISEASES – Varied clinical presentations of SLE, Scleroderma and Myositis. Use of laboratory testing in diagnosis. Treatment options in systemic lupus erythematosus. DAY 5 - VASCULITIS – Clinical manifestations of the various vasculitides and diagnostic evaluation. Treatment modalities used in vasculitis. SOFT TISSUE RHEUMATOLOGY – Diagnosis and treatment of soft tissue rheumatic conditions. Clinical aspects of entrapment neuropathies and their association with systemic conditions. MALE HYPOGONADISM CLINICAL FEATURES – “Male menopause”. Cost-effective strategy to investigate causes of male hypogonadism. Treat various endocrine conditions arising in men. PITUITARY POTPOURRI – Differential diagnosis based on clinical features. Laboratory workup using a “best test” approach. Treatment options.

SPECIFIC OBJECTIVES – DAY 1 - HYPERTENSIVE UPDATE: CREEPING UP ON A SILENT KILLER – JNC guidelines in the treatment of hypertension. Selection of different antihypertensive agents in select subgroups of patients. The newest antihypertensive agents and the rationale for choosing these over older agents. ANEMIA – Guidelines for diagnosing anemia in children and adults. Common diagnostic studies available for diagnosing the etiology of the anemia. Role of consultants in the evaluation and management of anemia. COMMUNITY ACQUIRED PNEUMONIA: DIAGNOSING AND TREATING THE #1 CAUSE OF DEATH IN THE U.S. FROM INFECTIOUS DISEASES – How to stratify your patients with CAP into those needing outpatient (most) vs. inpatient (few) treatment, using the PORT scoring system. Antibiotic options in treating CAP including the role of respiratory tract fluoroquinolones, and newest macrolide agents as well as more conventional therapies. Role and timing of ordering chest x-rays, blood cultures and initiation of antibiotic therapy. DEPRESSION IN PRIMARY CARE – The incidence and prevalence of anxiety and depression. Signs and symptoms associated with anxiety and depression. Treatment strategies available. DAY 2 - ASTHMA – Epidemiology of asthma. Modalities to diagnose asthma. Different treatments for asthma, both pharmacological and environmental. CURRENT TRENDS IN THE DIAGNOSIS AND TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE – Increase awareness of the large number of your patients who suffer from COPD, and who are currently going undiagnosed. Diagnose those with COPD within a single office visit. Current GOLD guidelines, in the diagnosis and treatment of those with COPD. CORONARY ARTERY DISEASE – Common presenting symptom complexes of patients. The diagnostic evaluation of a patient with chest pain. Current medication and surgical treatment options. CARE OF THE DIABETIC PATIENT – Benefits of a multidisciplinary approach to the management of DM and the critical role of the Primary Care Physician. Latest diagnostic criteria for diagnosing diabetes. Newest medications in the treatment of diabetes. DAY 3 - URINARY TRACT INFECTIONS – Uncomplicated and complicated UTIs, and why it is important to differentiate between the two. Importance of antimicrobial resistance when treating those with UTIs. Current guidelines in the treatment of uncomplicated cystitis, pyelonephritis and asymptomatic bacteriuria. IDENTIFICATION AND TREATMENT OF TRAUMATIZED PATIENTS – Characteristics associated with traumatic events. The “red flags” or symptomatic manifestations of trauma in patients. How to obtain a trauma history from a patient. Interventions designed to treat the symptoms of trauma. COLON CANCER PREVENTION – Patients who are at average and above average risk for developing colon cancer. Benefits and shortcomings of currently available means of colon cancer screening: from simple FOBT and genetic stool analysis to virtual colonoscopy and conventional colonoscopy. Latest advances in colon cancer screening. IMPROVING COMPLIANCE – Patient/physician communication issues that enhance compliance. Techniques to increase compliance. Follow-up plan for each STI. DAY 4 - EATING DISORDERS – Behavioral and psychosocial triggers that promote eating disordered behaviors. Anorexia, bulimia and binge eating behaviors. Clinical “red flags” that indicate eating disordered behavior. Interventions designed to treat eating disordered behaviors. DEVELOPMENTAL SCREENING OF INFANTS AND YOUNG CHILDREN – Prevalence of developmental and behavioral disorders in children. Standardized developmental screening tools available for use. Strategies to provide periodic screening in the office based setting. ADULT HEALTH SCREENING UPDATE – Current primary care guidelines for recommended screening tests for adults. Recommended immunizations for adults. FEVER IN THE YOUNG INFANT – Common etiologies of serious bacterial infection in neonates and infants and select appropriate therapies. Evaluation of the febrile neonate and infant, and differences in published criteria. The intolerance of serious bacterial infection in the neonate and infant. DAY 5 - SMOKING CESSATION – Role of smoking in disease etiology. Smoking cessation techniques. CARING FOR THE ADOLESCENT PATIENT – Strategy for conducting adolescent interviews that will address appropriate confidentiality issues. Prevalence of various at risk behaviors in the adolescent patient. Sexual maturity ratings for puberty and when delayed sexual maturity should be suspected. OBESITY – Epidemiology of obesity in America and the health risks associated with obesity. Patients that are obese and that are in need of treatment. Treatment options available, including diet, exercise, medications, and bariatric surgery. PEDIATRIC IMMUNIZATIONS AND SCREENING – Appropriate pediatric screening to be done during the first five years of life. Appropriate immunizations and time of immunizations for this age group.